Given its prevalence, a great effort has been made to understand the mechanisms that lead to its development including genetic analysis, mutation status for known oncogenes ad tumor suppresors, expression status of known associated receptors like ER and ERBB2 (HER2), as well as transcriptomic assays as exemplified in Cancer Genome Atlas Network (2). The gene discussed is ERBB2; the disease is neoplasm.